Lilly Partners with Prime Therapeutics: How Next Generation Value-based Arrangements Put Patients First
Value-based arrangements (VBA) are increasingly used, although most medicines are paid based on volume of product purchased or cost per [...]
PBMs Report Ease in Demand for Hydroxychloroquine
Pharmacy benefit managers last month reported an easing of demand for the antimalarial drug hydroxychloroquine following a rapid surge spurred [...]
Prime Therapeutics Program Posts 9:1 ROI
A program by Prime Therapeutics posted a 9:1 return on the original investment, the PBM announced. According to a press [...]
Prime Therapeutics Initiative Aims to Help Plan Sponsors Pay for Gene Therapies
The new PreserveRx program from Prime Therapeutics looks to help plan sponsors deal with high-cost gene therapies, Fierce Healthcare reports. [...]
Advertisement
